Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 8,803 | N/A | N/A |
| Receivables | 237 | N/A | N/A |
| TOTAL | $9,266 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 2,070 | N/A | N/A |
| Intangibles | 2,699 | 0 | 0 |
| Other Non-Current Assets | 148 | 0 | 0 |
| TOTAL | $4,917 | $N/A | $N/A |
| Total Assets | $14,183 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 1,258 | N/A | N/A |
| Accounts payable and accrued liabilities | 930 | 0 | 0 |
| Accrued Expenses | 1,127 | N/A | N/A |
| TOTAL | $4,172 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 2,945 | N/A | N/A |
| Deferred Revenues | 857 | N/A | N/A |
| Other Non-Current Liabilities | 1,493 | 0 | 0 |
| TOTAL | $9,572 | $N/A | $N/A |
| Total Liabilities | $13,744 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1 | N/A | N/A |
| Retained earnings | -43,881 | N/A | N/A |
| Other shareholders' equity | 44,319 | 0 | 0 |
| TOTAL | $439 | $N/A | $N/A |
| Total Liabilities And Equity | $14,183 | $0 | $0 |